Such a cytogenetic and molecular alteration has been recognized as the hallmark of the disease, and in vivo animal models have shown that bcr‐abl is the sole molecular change responsible for CML induction 26. The gene discussed is ABL1; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.